Denavir OTC Switch Falters On Viral Resistance Questions
Executive Summary
Two FDA advisory committees unanimously disagreed on whether to recommend approval of the Rx-to-OTC switch of SmithKline Beecham's Denavir 1% penciclovir cream for cold sores on Dec. 1.